Zoloft and Appetite decreased - a phase IV clinical study of FDA data

Summary:

Appetite decreased is found among people who take Zoloft, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Zoloft and have Appetite decreased. It is created by eHealthMe based on reports of 122,114 people who have side effects when taking Zoloft from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

122,114 people reported to have side effects when taking Zoloft.
Among them, 2,205 people (1.81%) have Appetite decreased.

What is Zoloft?

Zoloft has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 132,354 Zoloft users for its effectiveness, alternative drugs and more.

What is Appetite decreased?

Appetite decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 4,265 drugs and 4,299 conditions by eHealthMe.

Number of Zoloft and Appetite decreased reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Zoloft and have Appetite decreased?

Check whether Appetite decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .

Related studies

How severe was Appetite decreased and when was it recovered:

Appetite decreased in Zoloft

Expand to all the drugs that have ingredients of sertraline hydrochloride:

Appetite decreased and drugs with ingredients of sertraline hydrochloride (4,639 reports)

Alternative drugs to, pros and cons of Zoloft:

Zoloft (132,354 reports)

Common Zoloft side effects:

Stress and anxiety: 9,019 reports
Depression: 8,834 reports
Fatigue (feeling of tiredness): 8,501 reports
Drug ineffective: 7,729 reports
Headache (pain in head): 7,422 reports
Pain: 7,095 reports
Weakness: 6,527 reports

Browse all side effects of Zoloft:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Appetite decreased treatments and more:

Appetite decreased (223,282 reports)

COVID vaccines that are related to Appetite decreased:

Common drugs associated with Appetite decreased:

All the drugs that are associated with Appetite decreased:

Appetite decreased (4,265 drugs)

Common conditions associated with Appetite decreased:

Type 2 diabetes: 10,766 reports
High blood pressure: 10,483 reports
Rheumatoid arthritis: 7,499 reports
Pain: 7,126 reports
Multiple myeloma: 6,537 reports

All the conditions that are associated with Appetite decreased:

Appetite decreased (4,299 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sertraline hydrochloride (the active ingredients of Zoloft) and Zoloft (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.